Author

Steven R. Grossman

University of Southern CaliforniaORCID 0009-0003-4692-6925Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Kranthi Kumar ChougoniiD· 2 shared Ann E. WaltsiD· 1 shared Bin HuiD· 1 shared Boxiao DingiD· 1 shared Bradford E. WindleiD· 1 shared Diana T. DconaiD· 1 shared Eziafa OduahiD· 1 shared Hisashi HaradaiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Kranthi Kumar ChougoniORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyScientific ReportsPeer-reviewedDec 6, 2025

Combined inhibition of NAD synthesis and C-terminal binding protein cooperatively induce cell death and inhibit growth of High Grade Serous Ovarian Carcinoma

Kranthi Kumar Chougoni, Jacqueline L. West, Nicholette St. Martin…·Steven R. Grossman

The paper shows that combining CtBP inhibitors with NAD synthesis inhibitors enhances cell death and inhibits growth of high-grade serous ovarian carcinoma.

DOI 10.1038/s41598-025-30990-7

humanproteomics

𝕏 PostBluesky

Cancer BiologyCancer Research CommunicationsPeer-reviewedSep 20, 2024

Oncogenic Mutant p53 Sensitizes Non-Small Cell Lung Cancer Cells to Proteasome Inhibition via Oxidative Stress-Dependent Induction of Mitochondrial Apoptosis

Kranthi Kumar Chougoni, Victoria L. Neely, Boxiao Ding…·Steven R. Grossman

This study shows proteasome inhibitors are more effective against NSCLC cells with mutant p53 by inducing oxidative stress and mitochondrial apoptosis, suggesting a new therapeutic strategy.

7 citations

humanproteomics

𝕏 PostBluesky